Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning From Long-Term, Full-Agonist Opioid Therapy Among Veterans With Chronic Pain
Edmond S, Wesolowicz D, Snow J, Currie S, Jankelovits A, Chhabra M, Becker W. Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning From Long-Term, Full-Agonist Opioid Therapy Among Veterans With Chronic Pain. Journal Of Pain 2023, 25: 132-141. PMID: 37549775, DOI: 10.1016/j.jpain.2023.07.027.Peer-Reviewed Original ResearchConceptsFull agonist opioidsChronic painOpioid therapyPatient-centered approachPain careSide effectsPatient experienceLong-term opioid therapyRacial disparitiesEquivalent pain controlHarms outweigh benefitsPain treatment disparitiesUse of buprenorphinePatient-provider communicationPartial agonist buprenorphineExperiences of patientsPatient-centered careBenefits of buprenorphineLess analgesiaPain controlMost patientsPrevious regimensProvider referralPain managementPain treatmentArguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits
Edmond SN, Snow JL, Pomeranz J, Van Cleve R, Becker WC. Arguments for and Against a New Diagnostic Entity for Patients With Chronic Pain on Long-Term Opioid Therapy for Whom Harms Outweigh Benefits. Journal Of Pain 2021, 23: 958-966. PMID: 34974174, DOI: 10.1016/j.jpain.2021.12.006.Peer-Reviewed Original ResearchConceptsLong-term opioid therapyOpioid use disorderNew diagnostic entityOpioid therapyDiagnostic entityOUD diagnosisChronic painOUD criteriaHarms outweigh benefitsNeeds of patientsDSM-5Larger Delphi studyUse disordersPatient experiencePatientsThematic qualitative methodsInternal medicineTherapyImproved treatmentExpert panelPainOutweigh benefitsBiological underpinningsDiagnosisThree-quarters